29.12.2020 16:36:00

The Market Court's decision relating to Mehiläinen Yhtiöt Oy's expired voluntary public cash tender offer for all shares in Pihlajalinna Plc

HELSINKI, Dec. 29, 2020 /PRNewswire/ -- Mehiläinen Yhtiöt Oy, Stock Exchange Release, 29 December 2020 at 5:15 p.m. (EET)

Mehiläinen Yhtiöt Oy ("Mehiläinen") announced on 25 November 2020 that it would not complete the public tender offer it had made for all issued and outstanding shares in Pihlajalinna Plc ("Pihlajalinna") (the "Tender Offer"). In connection therewith, Mehiläinen confirmed that it would continue the proceedings before the Market Court with the aim of obtaining the Market Court's decision on the proposed combination of Mehiläinen and Pihlajalinna, and that it would separately announce the outcome of such proceedings.

Further to the above, Mehiläinen announces that the Market Court has today rendered its decision in the matter. According to the decision, the Market Court has found that due to the expiry of the Tender Offer, the prerequisites for any further handling of the matter at the Market Court have lapsed. Accordingly, the Market Court has not opined on the proposed combination of Mehiläinen and Pihlajalinna and instead decided that the handling of the matter shall lapse.

Contacts for media and investor inquiries:

Mehiläinen

Janne-Olli Järvenpää, CEO of Mehiläinen

Requests for contacts through Mehiläinen's communications:
Communications Director Laura Martinsuo
tel. +358 40 196 2892
laura.martinsuo@mehilainen.fi

Mehiläinen in brief:

Now 111 years old, Mehiläinen is a rapidly developing and growing private provider of healthcare and social care services, offering comprehensive high-quality services to private, corporate, municipal and insurance customers. Mehiläinen provides help, support and care for approximately 1.3 million customers every year across Finland. In 2019, our revenue was EUR 1064.1 million and our customers were cared for by more than 21,800 employees and private practitioners at over 500 locations. In all of its business areas, Mehiläinen invests in high-quality health care with an impact and develops and exports Finnish digital healthcare know-how across the world as a forerunner in its field.

IMPORTANT INFORMATION

THIS STOCK EXCHANGE RELEASE MAY NOT BE RELEASED, PUBLISHED OR OTHERWISE DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO ANY JURISDICTION IN WHICH IT WOULD BE PROHIBITED BY APPLICABLE LAW TO DO SO. THIS STOCK EXCHANGE RELEASE DOES NOT CONSTITUTE A TENDER OFFER OR AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL ANY SECURITIES DESCRIBED HEREIN.

Forward-looking statements

This stock exchange release contains statements that, to the extent they are not historical facts, constitute "forward-looking statements". Forward-looking statements include statements concerning plans, expectations, projections, objectives, targets, goals, strategies, future events, future revenues or performance, capital expenditures, financing needs, plans or intentions relating to acquisitions, competitive strengths and weaknesses, plans or goals relating to financial position, future operations and development, business strategy and the trends in the industries and the political and legal environment and other information that is not historical information. In some instances, they can be identified by the use of forward-looking terminology, including the terms "believes", "intends", "may", "will" or "should" or, in each case, their negative or variations on comparable terminology. By their very nature, forward-looking statements involve inherent risks, uncertainties and assumptions, both general and specific, and risks exist that the predictions, forecasts, projections and other forward-looking statements will not be achieved. Given these risks, uncertainties and assumptions, investors are cautioned not to place undue reliance on such forward-looking statements. Any forward-looking statements contained herein speak only as at the date of this stock exchange release.

This information was brought to you by Cision http://news.cision.com

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!